Follow
In Vivo
In Vivo: are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, and plants, as opposed to a tissue extract or dead organism.
What's Popular in In Vivo
-
MAY 19, 2026Space & AstronomyHow could customizable drinks help provide astronauts on future, long-term space missions with the proper levels of nutr ...Written By: Laurence Tognetti, MScMAY 19, 2026eBooksCancer researchers rely on a spectrum of model systems to drive discovery, from classic murine syngeneic models to innov ...Sponsored By: Bio X CellMAY 18, 2026eBooksEfficient screening strategies are essential for identifying and advancing promising compounds across drug discovery pip ...APR 21, 2026Drug Discovery & DevelopmentCNS-3D Brain Organoids Predict Clinical Seizure Liability Central nervous system (CNS) toxicity accounts for 25% of safe ...APR 02, 2026ImmunologyRegulatory T cells (Tregs) are specialized immune cells that help maintain immune tolerance and prevent autoimmune disea ...Written By: Brian G. Morreale
MAY 19, 2026
Space & Astronomy
How could customizable drinks help provide astronauts on future, long-term space missions with the proper levels of nutr
...
Written By:
Laurence Tognetti, MSc
MAY 19, 2026
eBooks
Cancer researchers rely on a spectrum of model systems to drive discovery, from classic murine syngeneic models to innov
...
Sponsored By:
Bio X Cell
MAY 18, 2026
eBooks
Efficient screening strategies are essential for identifying and advancing promising compounds across drug discovery pip
...
APR 21, 2026
Drug Discovery & Development
CNS-3D Brain Organoids Predict Clinical Seizure Liability Central nervous system (CNS) toxicity accounts for 25% of safe
...
APR 02, 2026
Immunology
Regulatory T cells (Tregs) are specialized immune cells that help maintain immune tolerance and prevent autoimmune disea
...
Written By:
Brian G. Morreale
MAR 03, 2026
Drug Discovery & Development
Researchers have designed a nanomaterial that destroys cancer cells without harming surrounding healthy tissues in cell
...
Written By:
Annie Lennon
FEB 18, 2026
eBooks
Get Your Step-by-Step Roadmap to BsAb Discovery Successful bispecific antibody discovery hinges on early decisions that
...
Sponsored By:
WuXi Biologics CRO Services
OCT 27, 2025
eBooks
Addressing TCE Discovery Challenges with Expert Insights T-cell engagers (TCEs) are revolutionizing cancer immunotherapy
...
Sponsored By:
WuXi Biologics CRO Services
OCT 14, 2025
Cancer
Chemotherapy, anti-cancer drugs that stop the growth of tumor cells, encompasses a wide variety of different agents.&nbs
...
Written By:
Katie Kokolus
-
MAY 26, 2026 | 6:00 AMIn vivo studies often present challenges in evaluating T cell engagers (TCEs) due to their complex MOA and pharmacology. Reliable interpretation of PK/PD, efficacy, and safety data requires...JUN 11, 2026 | 8:00 AMDr. Marco A. M. Prado is a distinguished neuroscientist and Tier 1 Canada Research Chair in Neurochemistry of Dementia. His research focuses on how alterations in neurochemical signaling dri...MAY 14, 2026 | 10:00 AMNeurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are characterized by the abnormal aggregation of pathological proteins...MAR 31, 2026 | 8:00 AMAge is the single greatest risk factor for neurodegenerative disease, yet the cellular mechanisms that drive age-related protein accumulation in the brain remain incompletely understood. In...MAR 26, 2026 | 7:00 AMTLR4 agonists can drive potent antitumor immunity, but their clinical use has been constrained by systemic toxicities. We developed a chemically detoxified, liposome‑formulated TLR4 agonist d...
MAY 26, 2026 | 6:00 AM
In vivo studies often present challenges in evaluating T cell engagers (TCEs) due to their complex MOA and pharmacology. Reliable interpretation of PK/PD, efficacy, and safety data requires...
JUN 11, 2026 | 8:00 AM
Dr. Marco A. M. Prado is a distinguished neuroscientist and Tier 1 Canada Research Chair in Neurochemistry of Dementia. His research focuses on how alterations in neurochemical signaling dri...
MAY 14, 2026 | 10:00 AM
Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are characterized by the abnormal aggregation of pathological proteins...
MAR 31, 2026 | 8:00 AM
Age is the single greatest risk factor for neurodegenerative disease, yet the cellular mechanisms that drive age-related protein accumulation in the brain remain incompletely understood. In...
MAR 26, 2026 | 7:00 AM
TLR4 agonists can drive potent antitumor immunity, but their clinical use has been constrained by systemic toxicities. We developed a chemically detoxified, liposome‑formulated TLR4 agonist d...
FEB 19, 2026 | 7:00 AM
Discover how Iconeus One, the premier functional ultrasound (fUS) system for neuroscientists, is transforming brain function studies. Based on ultrafast plane-wave sonography, Iconeus One of...
NOV 19, 2025 | 3:00 PM
![[Webinar] Mass Spec Enables More Definitive Biologics Drug Discovery and Optimization](https://d3bkbkx82g74b8.cloudfront.net/eyJidWNrZXQiOiJsYWJyb290cy1pbWFnZXMiLCJrZXkiOiJzcGVha2VyX3Byb2ZpbGVfaW1hZ2VfMWIyM2Y3ODUyOGZmZjUwZjBjY2FlOTkwZWRmYThjODM2ZmFlYjA5M18zMjEwLmpwZyIsImVkaXRzIjp7InRvRm9ybWF0IjoianBnIiwicmVzaXplIjp7IndpZHRoIjoxNTAsImhlaWdodCI6MTUwLCJmaXQiOiJjb3ZlciIsInBvc2l0aW9uIjoiY2VudGVyIiwiYmFja2dyb3VuZCI6IiNmZmYifSwiZmxhdHRlbiI6eyJiYWNrZ3JvdW5kIjoiI2ZmZiJ9fX0=)
The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as post-translational modifications (PTMs) and sequence variants can affect pr...
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
OCT 22, 2025 | 12:00 PM
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
-
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...Labroots is pleased to announce the 3rd annual event in the Cell & Gene Therapy Virtual Event Series, taking place on October 13th, 2027. The Cell & Gene Therapy planning committee w...FEB 18, 2026 | 5:30 AM PSTC.E. CREDITSExperience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...OCT 08, 2025 | 8:00 AM PDTThe 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...SEP 10, 2025 | 6:30 AM PDTJoin us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is pleased to announce the 3rd annual event in the Cell & Gene Therapy Virtual Event Series, taking place on October 13th, 2027. The Cell & Gene Therapy planning committee w...
FEB 18, 2026
| 5:30 AM PST
C.E. CREDITS
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
OCT 08, 2025
| 8:00 AM PDT
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
SEP 10, 2025
| 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
FEB 19, 2025
| 6:00 AM PST
C.E. CREDITS
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 8 th Annual Event in the Drug Discovery & Development...
JUL 24, 2024
| 6:00 AM PDT
GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering . This event will feature leading experts from academia, pharma, and biotech, showcasing the tra...
JUN 04, 2024
| 8:00 AM PDT
Join us as we reveal the revolutionary capabilities of Bruker Cellular Analysis' Beacon Optofluidic system. The Beacon platform provides a complete picture of single cell function throug...
FEB 21, 2024
| 5:30 AM PST
Labroots and the Drug Discovery planning committee are pleased to announce its 7th Annual Event in the Drug Discovery & Development Virtual Event Series . Labroots will host this online-...